---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-002950"
form_type: "8-K"
ticker: "GCTK"
cik: "0001506983"
company_name: "Glucotrack, Inc."
filed_at: "2025-01-21T23:59:59+00:00"
generated_at: "2026-05-27T22:04:43.372020+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Glucotrack receives ISO 13485:2016 certification for quality management system

## Summary
- Certification awarded by British Standards Institute after Stage I and Stage II assessments.
- Covers design and development of Glucotrack's long-term implantable Continuous Blood Glucose Monitor (CBGM).
- ISO 13485 is the globally recognized standard for medical device QMS, aligned with FDA QMSR and used in the EU.
- CEO Paul Goode calls certification a major step toward delivering high-quality products.
- No financial updates or guidance changes provided in the announcement.

## SEC filing metadata
- accession: 0001493152-25-002950
- form_type: 8-K
- ticker: GCTK
- cik: 0001506983
- company_name: Glucotrack, Inc.
- filed_at: 2025-01-21T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1506983/000149315225002950/0001493152-25-002950-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1506983/000149315225002950/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-002950
- JSON: https://secwatch.observer/filing/0001493152-25-002950.json
- Plain text: https://secwatch.observer/filing/0001493152-25-002950.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.